Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Direct Detection of ESKAPE Pathogens From Whole Blood Using T2MR Bacteria Panel in Patients With Pyogenic Spondylodiscitis and Infective Endocarditis

NCT05644990 is registered in ClinicalTrials.gov with Charles University, Czech Republic as lead sponsor.

NCT NCT05644990
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05644990 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Direct Detection of ESKAPE Pathogens From Whole Blood Using T2MR Bacteria Panel in Patients With Pyogenic Spondylodiscitis and Infective Endocarditis
Lead sponsor
Charles University, Czech Republic
Phase
Observational
Overall status
Unknown status
Start date
September 1, 2022
Completion date
September 1, 2025
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

endocarditis, bacterial, osteomyelitis; vertebra